Can you please point me to where the company has stated that there will be a "30-day trial primary data readout"? I'm not saying the company did not say that, I just cannot find it.
Not sure if this excerpt from the filing on clinicaltrials.gov is what you are referring to -
"The study is designed to have three interim analyses for stopping accrual early for efficacy and futility when 30%, 45% and 60% of the 300 patients have reached the primary endpoint using Bayesian predictive probabilities."
How did you arrive at June 5th or any other date for a data readout?
Can you please point me to where the company has stated that...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.42 |
Change
-0.630(20.7%) |
Mkt cap ! $2.763B | |||
| Open | High | Low | Value | Volume |
| $2.65 | $2.75 | $2.37 | $86.50M | 34.45M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7000 | $2.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.42 | 8305 | 2 |
View Market Depth
| Last trade - 16.10pm 20/12/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
